Purpose of review: Therapeutic drug monitoring (TDM) is increasingly utilized as a strategy to optimize inflammatory bowel disease (IBD) therapeutics. As management paradigms have evolved towards treat-to-target strategies, there has been growing interest in expanding the role of TDM to guide drug optimization for achieving objective endpoints.


Biologic, Crohn's Disease, IBD, Inflammatory Bowel Disease, Therapeutic drug monitoring, Thiopurines, Ulcerative Colitis

Read More